טוען...
Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
Atrial fibrillation (AF) remains an important clinical problem with severe complications such as stroke, which especially harms those with risk factors as calculated by the CHADS(2) or CHA(2)DS(2)-VASc. Until now, no therapy has proven 100% effective against AF. Since the left atrial appendage (LAA)...
שמור ב:
| הוצא לאור ב: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5345987/ https://ncbi.nlm.nih.gov/pubmed/28293114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S89213 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|